z-logo
open-access-imgOpen Access
Development of ruxolitinib as a myelofibrosis therapy
Author(s) -
Srđan Verstovšek,
Aamer Aleem,
Abdulkareem Al-Momen,
KateJ Newberry
Publication year - 2013
Publication title -
journal of applied hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.107
H-Index - 2
eISSN - 2454-6976
pISSN - 1658-5127
DOI - 10.4103/1658-5127.123299
Subject(s) - ruxolitinib , medicine , myelofibrosis , adverse effect , myeloid , oncology , bone pain , bone marrow

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom